JPRN-UMIN000003712已完成2 期
A Phase II Study of Pemetrexed and EGFR-TKI in Patients with Non-Small Cell Lung Cancer After Failing EGFR-TKIs - A Phase II Study of Pemetrexed and EGFR-TKI in Patients with Non-Small Cell Lung Cancer After Failing EGFR-TKIs
Osaka Lung Cancer Study Group0 个研究点目标入组 25 人开始时间: 2010年6月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Using NSAIDs regularly. 2) Interstitial pneumonia/lung fibrosis on chest CT. 3) Previous drug allergy 4) History of poorly controlled pleural effusion, pericardial effusion and ascites. 5) Active infection. 6) Current Diarrhea. 7) Ileus or intestinal tract paralysis. 8) Symptomatic brain metastasis. 9) Active concomitant malignancy. 10) History of sever heart disease. 11) History of sever psychological disease. 12) Hoped to be pregnant/nursing. 13) Those judged to be not suitable by the attending physician.
研究者
相似试验
已完成
2 期
A Phase II Study of Pemetrexed and Gefitinib in Chemotherapy Naive Patients with Non-Small Cell Lung Cancer Harboring Mutations of EGFRon-Small Cell Lung CancerJPRN-UMIN000003808Osaka Lung Cancer Study Group26
未知
2 期
A Randomised Phase 2 Trial of Pemetrexed and Gefitinib Versus Gefitinib as First Line Treatment for Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor MutationsJPRN-jRCT1080221763Eli Lilly Japan K.K.
招募中
不适用
Study of pemetrexed in previously-treated patients with advanced squamous cell lung carcinoma having low level of TSKCT0003518CC Hospital32
已完成
不适用
Clinical study of a combined use of EGFR-TKI and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000001966Juntendo University, School of Medicine10
已完成
1 期
A Phase I/II study of Pemetrexed plus Erlotinib therapy in Previously Treated Non-Small-Cell Lung Cancer.on-small cell lung cancerJPRN-UMIN000002900Osaka Univ.Hospital Respiratory Medicine40
